OMI Overview

OMI is combining the newest research and technology advances with direct patient involvement to develop needed therapies for a range of diseases. The Institute’s immediate research efforts focus on poorly understood diseases such as ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome), Autism, Lyme, Multiple Sclerosis, and other neuro-immune conditions. OMI will apply our unique translational model to a wide range of diseases such as blood cancers and cardiovascular disease.
Read More

Institute Video

Learn more about OMI’s vision to work outside the box developing a collaborative, patient-focused health care model. Video highlights Andreas Kogelnik, founder and Director of OMI and Board members and Advisors including Ron Davis, PhD; Tom Fogarty, MD; Jay Levy, MD; Dan Peterson, MD; and Randy Scott, PhD.

Help Us Help You

Our work is made possible by generous donations from individuals, foundations and corporations through the Open Medicine Foundation (OMF).
Help us make a difference for millions of patients worldwide!
Donate Now
Keep updated on our progress: